Cutler Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-745
| Closed | -$136K | – | 3048 |
|
|
2021
Q2 | $136K | Sell |
745
-105
| -12% | -$19.2K | 0.01% | 869 |
|
|
2021
Q1 | $129K | Sell |
850
-5,700
| -87% | -$865K | 0.01% | 814 |
|
|
2020
Q4 | $1.02M | Buy |
6,550
+3,450
| +111% | +$539K | 0.05% | 219 |
|
|
2020
Q3 | $354K | Buy |
3,100
+2,300
| +288% | +$263K | 0.02% | 357 |
|
|
2020
Q2 | $89K | Sell |
800
-2,300
| -74% | -$256K | 0.01% | 680 |
|
|
2020
Q1 | $278K | Buy |
3,100
+500
| +19% | +$44.8K | 0.01% | 359 |
|
|
2019
Q4 | $281K | Buy |
2,600
+1,200
| +86% | +$130K | 0.02% | 426 |
|
|
2019
Q3 | $137K | Buy |
1,400
+600
| +75% | +$58.7K | 0.01% | 527 |
|
|
2019
Q2 | $104K | Buy |
800
+700
| +700% | +$91K | 0.01% | 684 |
|
|
2019
Q1 | $13K | Sell |
100
-1,399
| -93% | -$182K | ﹤0.01% | 1157 |
|
|
2018
Q4 | $145K | Buy |
1,499
+392
| +35% | +$37.9K | 0.01% | 485 |
|
|
2018
Q3 | $153K | Sell |
1,107
-4,003
| -78% | -$553K | 0.01% | 626 |
|
|
2018
Q2 | $634K | Buy |
5,110
+861
| +20% | +$107K | 0.05% | 291 |
|
|
2018
Q1 | $473K | Sell |
4,249
-13,051
| -75% | -$1.45M | 0.04% | 317 |
|
|
2017
Q4 | $2.07M | Sell |
17,300
-6,758
| -28% | -$808K | 0.08% | 128 |
|
|
2017
Q3 | $3.38M | Sell |
24,058
-65,177
| -73% | -$9.14M | 0.13% | 93 |
|
|
2017
Q2 | $10.9M | Buy |
89,235
+48,763
| +120% | +$5.93M | 0.4% | 35 |
|
|
2017
Q1 | $4.91M | Buy |
40,472
+10,652
| +36% | +$1.29M | 0.2% | 76 |
|
|
2016
Q4 | $3.65M | Buy |
29,820
+12,220
| +69% | +$1.49M | 0.13% | 84 |
|
|
2016
Q3 | $2.16M | Buy |
17,600
+5,400
| +44% | +$662K | 0.1% | 105 |
|
|
2016
Q2 | $1.42M | Buy |
12,200
+12,000
| +6,000% | +$1.4M | 0.07% | 136 |
|
|
2016
Q1 | $27K | Sell |
200
-395
| -66% | -$53.3K | ﹤0.01% | 1593 |
|
|
2015
Q4 | $113K | Buy |
+595
| New | +$113K | 0.01% | 975 |
|